Sökning: "Kjell Grankvist"
Visar resultat 1 - 5 av 12 avhandlingar innehållade orden Kjell Grankvist.
1. Mechanisms of alloxan diabetogenicity
Sammanfattning : Suspensions of pancreatic islet cells from ob/ob-mice were incubated with Trypan Blue. Microscope photometry showed that apparently viable cells excluded the dye completely, whereas the nuclei of non-viable cells accumulated Trypan Blue by a saturable process. LÄS MER
2. Manipulation of potassium ion fluxes to induce apoptosis in lung cancer cells
Sammanfattning : Apoptosis is a special form of cell death that if non-functional may lead to diseases such as cancer. A reduction of the intracellular potassium ion (K+) content is necessary for activating enzymes important for the execution of apoptosis. LÄS MER
3. Improving venous blood specimen collection practices : method development and evaluation of an educational intervention program
Sammanfattning : Background: About 60%–80% of decisions regarding diagnosis and treatment are based on laboratory test results. Low adherence to venous blood specimen collection (VBSC) guidelines may lead to erroneous or delayed test results, causing patient harm and high healthcare costs. LÄS MER
4. Vascular endothelial growth factor in renal cell carcinoma
Sammanfattning : Background. Angiogenesis is essential for tumour growth. Vascular endothelial growth factor (VEGF) and its isoforms were investigated in relation to the clinical course in a large number of patients with renal cell carcinoma (RCC). Methods. LÄS MER
5. Cisplatin-resistance and cell death in malignant pleural mesothelioma cells
Sammanfattning : Malignant pleural mesothelioma (MPM) is an aggressive, treatment-resistant tumour. Cisplatin (cis-diamminedichloroplatinum (II)) is the best single-agent chemotherapy for MPM, but platinum-based combination therapies give the best overall response rates. However, cisplatin use is limited by resistance and severe side effects. LÄS MER